Mounica Vallurupalli
I am a physician-scientist interested in functional genomics, transcriptional regulation and myeloid disease biology.
Search
Search results
302 results found
An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome
Ebert, B. L., N. Galili, P. Tamayo, J. Bosco, R. Mak, J. Pretz, S. Tanguturi, et al. 2008. “An Erythroid Differentiation Signature Predicts Response to Lenalidomide in Myelodysplastic Syndrome”. PLoS Med 5: e35.
Cas9 activates the p53 pathway and selects for p53-inactivating mutations
Enache, O. M., V. Rendo, M. Abdusamad, D. Lam, D. Davison, S. Pal, N. Currimjee, et al. 2020. “Cas9 Activates the P53 Pathway and Selects for P53-Inactivating Mutations”. Nat Genet 52: 662-68.
Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations
Enache, O. M., V. Rendo, M. Abdusamad, D. Lam, D. Davison, S. Pal, N. Currimjee, et al. 2020. “Author Correction: Cas9 Activates the P53 Pathway and Selects for P53-Inactivating Mutations”. Nat Genet 52: 748-49.
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
Ferrando, A. A., D. S. Neuberg, J. Staunton, M. L. Loh, C. Huard, S. C. Raimondi, F. G. Behm, et al. 2002. “Gene Expression Signatures Define Novel Oncogenic Pathways in T Cell Acute Lymphoblastic Leukemia”. Cancer Cell 1: 75-87.
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
Fuchs, B. C., Y. Hoshida, T. Fujii, L. Wei, S. Yamada, G. Y. Lauwers, C. M. McGinn, et al. 2014. “Epidermal Growth Factor Receptor Inhibition Attenuates Liver Fibrosis and Development of Hepatocellular Carcinoma”. Hepatology 59: 1577-90.
Comment on "The consensus coding sequences of human breast and colorectal cancers"
Getz, G., H. Hofling, J. P. Mesirov, T. R. Golub, M. Meyerson, R. Tibshirani, and E. S. Lander. 2007. “Comment on ‘The Consensus Coding Sequences of Human Breast and Colorectal Cancers’”. Science 317: 1500.
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia
Golub, T. R., G. F. Barker, S. K. Bohlander, S. W. Hiebert, D. C. Ward, P. Bray-Ward, E. Morgan, S. C. Raimondi, J. D. Rowley, and D. G. Gilliland. 1995. “Fusion of the TEL Gene on 12p13 to the AML1 Gene on 21q22 in Acute Lymphoblastic Leukemia”. Proc Natl Acad Sci U S A 92: 4917-21.
The TEL gene and human leukemia
Golub, T. R., T. McLean, K. Stegmaier, M. Carroll, M. Tomasson, and D. G. Gilliland. 1996. “The TEL Gene and Human Leukemia”. Biochim Biophys Acta 1288: M7-10.
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring
Golub, T. R., D. K. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek, J. P. Mesirov, H. Coller, et al. 1999. “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring”. Science 286: 531-7.